...
首页> 外文期刊>Clinical and experimental ophthalmology >Photodynamic therapy with Verteporfin for vascular leakage from a combined hamartoma of the retina and retinal pigment epithelium.
【24h】

Photodynamic therapy with Verteporfin for vascular leakage from a combined hamartoma of the retina and retinal pigment epithelium.

机译:Verteporfin的光动力疗法可治疗视网膜和视网膜色素上皮联合错构瘤的血管渗漏。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

This interventional case report describes a patient with a combined hamartoma of the retina and retinal pigment epithelium (RPE), which was treated with photodynamic therapy (PDT) with Verteporfin. A 17-year-old girl presented with a combined hamartoma of the retina and RPE. Progressive decrease in vision due to vascular leakage and macular involvement led to the decision to treat this lesion with PDT. Rapid vascular closure occurred after PDT as confirmed by fundus fluorescein angiography and the clinical appearance gradually improved. However, visual acuity did not improve substantially. PDT with Verteporfin could be considered as a treatment modality for combined hamartomas of the retina and RPE, which demonstrate progressive vascular leakage.
机译:该介入病例报告描述了患有视网膜和视网膜色素上皮(RPE)合并错构瘤的患者,接受了Verteporfin的光动力疗法(PDT)的治疗。一名17岁女孩患有视网膜和RPE合并的错构瘤。由于血管渗漏和黄斑受累导致视力逐渐下降,因此决定用PDT治疗该病灶。经眼底荧光血管造影证实,PDT后迅速发生血管闭合,临床表现逐渐好转。但是,视力没有明显改善。具有维替泊芬的PDT可以被认为是视网膜和RPE合并错构瘤的治疗方式,表现出进行性血管渗漏。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号